Found: 34
Select item for more details and to access through your institution.
WNT5A is a putative epi‐driver of prostate cancer metastasis to the bone.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 16, p. 1, doi. 10.1002/cam4.70122
- By:
- Publication type:
- Article
Simulating Progression-Free and Overall Survival for First-Line Doublet Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients Based on Real-World Registry Data.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Real-World Treatment and Outcomes of Metastatic Colorectal Cancer Patients With a Poor or Very Poor Performance Status.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Primary Tumor Resection and Overall Survival in Patients With Metastatic Colorectal Cancer Treated With Palliative Intent.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Impact of Primary Tumor Site on Bevacizumab Efficacy in Metastatic Colorectal Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
COVID-19 Vaccine Hesitancy in Australian Patients with Solid Organ Cancers.
- Published in:
- Vaccines, 2022, v. 10, n. 9, p. 1373, doi. 10.3390/vaccines10091373
- By:
- Publication type:
- Article
Serious Underlying Medical Conditions and COVID-19 Vaccine Hesitancy: A Large Cross-Sectional Analysis from Australia.
- Published in:
- Vaccines, 2022, v. 10, n. 6, p. N.PAG, doi. 10.3390/vaccines10060851
- By:
- Publication type:
- Article
Resection of colorectal cancer liver metastases in older patients.
- Published in:
- ANZ Journal of Surgery, 2020, v. 90, n. 5, p. 796, doi. 10.1111/ans.15750
- By:
- Publication type:
- Article
Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 198, n. 1, p. 67, doi. 10.1007/s10549-022-06856-1
- By:
- Publication type:
- Article
Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 197, n. 3, p. 67, doi. 10.1007/s10549-022-06856-1
- By:
- Publication type:
- Article
Potentially actionable FGFR2 high-level amplification in thymic sebaceous carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Acute granulomatous interstitial nephritis in a patient with metastatic melanoma on targeted therapy with dabrafenib and trametinib—A case report.
- Published in:
- Cancer Reports, 2022, v. 5, n. 7, p. 1, doi. 10.1002/cnr2.1520
- By:
- Publication type:
- Article
Complementary Medicine Use Amongst Patients with Metastatic Cancer Enrolled in Phase III Clinical Trials.
- Published in:
- Oncologist, 2022, v. 27, n. 3, p. e286, doi. 10.1093/oncolo/oyac020
- By:
- Publication type:
- Article
Accuracy and Prognostic Significance of Oncologists' Estimates and Scenarios for Survival Time in Advanced Gastric Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1102, doi. 10.1634/theoncologist.2018-0613
- By:
- Publication type:
- Article
The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic pattern.
- Published in:
- Acta Oncologica, 2018, v. 57, n. 11, p. 1438, doi. 10.1080/0284186X.2018.1487581
- By:
- Publication type:
- Article
Patient demographics and management landscape of metastatic colorectal cancer in the third‐line setting: Real‐world data in an australian population.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 2, p. e56, doi. 10.1111/ajco.13553
- By:
- Publication type:
- Article
Efficacy of late line pertuzumab with trastuzumab and chemotherapy in HER2‐positive metastatic breast cancer: An Australian case series.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2019, v. 15, n. 6, p. 377, doi. 10.1111/ajco.13195
- By:
- Publication type:
- Article
Right versus left sided metastatic colorectal cancer: Teasing out clinicopathologic drivers of disparity in survival.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2019, v. 15, n. 3, p. 136, doi. 10.1111/ajco.13135
- By:
- Publication type:
- Article
How accurate are medical oncologists’ impressions of management of metastatic colorectal cancer in Australia?
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2018, v. 14, n. 2, p. e167, doi. 10.1111/ajco.12671
- By:
- Publication type:
- Article
The impact of bevacizumab in metastatic colorectal cancer with an intact primary tumor: Results from a large prospective cohort study.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2017, v. 13, n. 4, p. 314, doi. 10.1111/ajco.12639
- By:
- Publication type:
- Article
Radiation recall pneumonitis induced by erlotinib after palliative thoracic radiotherapy for lung cancer: Case report and literature review.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2016, v. 12, n. 1, p. 91, doi. 10.1111/ajco.12447
- By:
- Publication type:
- Article
COSA Convenors' Welcome 2015.
- Published in:
- 2015
- By:
- Publication type:
- Other
Novel quality indicators for metastatic colorectal cancer management identify significant variations in these measures across treatment centers in Australia.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2015, v. 11, n. 3, p. 262, doi. 10.1111/ajco.12355
- By:
- Publication type:
- Article
Severe contact esophagitis in a patient taking crizotinib: A case report.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2015, v. 11, n. 2, p. 187, doi. 10.1111/ajco.12341
- By:
- Publication type:
- Article
Multicenter randomized, open-label phase II trial of sequential erlotinib and gemcitabine compared with gemcitabine monotherapy as first-line therapy in elderly or ECOG PS two patients with advanced NSCLC.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2015, v. 11, n. 1, p. 4, doi. 10.1111/ajco.12178
- By:
- Publication type:
- Article
Implementing 'Goals of Care' discussion and palliative care referral for patients with advanced lung cancer: an outpatient‐based pilot project.
- Published in:
- Internal Medicine Journal, 2021, v. 51, n. 4, p. 540, doi. 10.1111/imj.14817
- By:
- Publication type:
- Article
Chemotherapy and biologic use in the routine management of metastatic colorectal cancer in Australia: is clinical practice following the evidence?
- Published in:
- Internal Medicine Journal, 2019, v. 49, n. 4, p. 446, doi. 10.1111/imj.14115
- By:
- Publication type:
- Article
ICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Pertuzumab study in the neoadjuvant setting for HER2‐positive nonmetastatic breast cancer in Australia (PeRSIA).
- Published in:
- International Journal of Cancer, 2023, v. 152, n. 2, p. 267, doi. 10.1002/ijc.34245
- By:
- Publication type:
- Article
Evaluation of response from axitinib per response evaluation Criteria in Solid Tumors versus Choi criteria in previously treated patients with metastatic renal cell carcinoma.
- Published in:
- OncoTargets & Therapy, 2016, v. 9, p. 2855, doi. 10.2147/OTT.S102578
- By:
- Publication type:
- Article
Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
BRAFV600E Mutations Arising from a Left-Side Primary in Metastatic Colorectal Cancer: Are They a Distinct Subset?
- Published in:
- Targeted Oncology, 2021, v. 16, n. 2, p. 227, doi. 10.1007/s11523-021-00793-7
- By:
- Publication type:
- Article
Successfully Improving Access and Accrual to Oncology Clinical Trials.
- Published in:
- 2007
- By:
- Publication type:
- Editorial